Image

Epigallocatechin Gallate (EGCG) as a Flushing Agent During Full Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis

Recruiting
20 - 40 years of age
Both
Phase N/A

Powered by AI

Overview

This study evaluates the effect of two flushing agents (epigallocatechin gallate (EGCG) and sodium hypochlorite (NaOCl)) during full pulpotomy using two different calcium silicate-based materials (MTA and premixed bioceramic putty) on postoperative pain, success rate and dentin bridge thickness in mature permanent mandibular molars with irreversible pulpitis. Participants will be divided into four groups based on the flushing fluid and the pulp capping material to be used.

Eligibility

Inclusion Criteria:

  1. Patients of either gender between the age group of 20-40 years.
  2. Systemically healthy patient (ASA I or II).
  3. Mature permanent mandibular molars with:
    • Extremely deep carious lesion (caries penetrating entire thickness of dentin).
    • Clinical diagnosis of symptomatic irreversible pulpitis and normal periapical tissue.
  4. Patients who agree to provide written consent and attend for recall appointments.

Exclusion Criteria:

  1. Non-restorable teeth with subgingival caries or badly broken teeth.
  2. Signs of pulpal necrosis; associated sinus tract or swelling.
  3. Negative response to pulp sensibility test.
  4. Poor periodontal support.
  5. Absence of pulp exposure following complete caries removal.
  6. Bleeding from the pulp could not be detected from one or more of the orifices indicating pulp necrosis.
  7. Failure to achieve haemostasis within 10 min following full pulpotomy.

Study details

Irreversible Pulpitis

NCT05811403

Cairo University

7 March 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.